课题基金 / 基金详情

2023 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar

2023 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar
2023癌症纳米技术戈登研究大会暨戈登研究研讨会
批准号:
10609291
负责人:
Darrell J Irvine
金额:
$0.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-01 至 2023-07-31

项目摘要

项目成果

Darrell J Irvine的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 2023年癌症纳米技术戈登研究会议(CN-GRC)提供了一个独特和高度 广受好评的论坛,在这里,处于职业生涯各个阶段的科学家可以分享未发表的、创新的癌症 纳米技术的使用使研究成为可能。自2011年以来,该会议每两年举行一次, 上座率强劲且稳步增长。为了进一步支持这一领域的新兴一代科学家, 癌症纳米技术戈登研究研讨会(CN-GRS)将与 GRC,重点介绍研究生和博士后的演讲。这次会议是一个重要的会场,带来了 化学家、物理学家、工程师、生物学家、临床医生、行业领袖和监管专家共同关注 关于癌症纳米技术这一高度交叉的科学。本次会议将特别关注两个问题 癌症研究的两端:加深我们对癌症相互作用的基本理解 纳米材料与肿瘤和体内环境,以及癌症纳米技术的实验室转化 然后进了诊所。 会议将把一群活跃的杰出科学家聚集在宁静而风景秀丽的沃特维尔 为了:1)由代表国家和地区的专家分享癌症纳米技术的尖端研究 生命科学的全部领域;2)促进讨论、思想交流和促进合作;3) 加强青年科学家的培养和发展,促进多样性。CN-GRC的高度优先事项 CN-GRS是为了增加参与者的多样性。为实现这一目标,请拨经费用于旅行和 向女性和代表不足的发言者提供登记支助
英文摘要
Abstract The 2023 Cancer Nanotechnology Gordon Research Conference (CN-GRC) provides a unique and highly acclaimed forum where scientists at every stage of their career can share unpublished, innovative cancer research made possible by the use of nanotechnology. Held biennially since 2011, the conference has had a strong and steadily growing attendance. To further support the emerging generation of scientists in this field, the Cancer Nanotechnology Gordon Research Seminar (CN-GRS) will be carried out in conjunction with the GRC, highlighting talks by graduate students and postdocs. This conference is an important venue bringing together chemists, physicists, engineers, biologists, clinicians, industry leaders and regulatory experts focused on the highly interdisciplinary science of cancer nanotechnology. This meeting will particularly focus on two ends of the spectrum in cancer research: deepening our fundamental understanding of the interactions of nanomaterials with tumors and the in vivo environment, and translation of cancer nanotechnology out of the lab and into the clinic. The conference will bring together a lively group of exceptional scientists to peaceful and scenic Waterville Valley, NH in order to: 1) share cutting-edge research in cancer nanotechnology by experts representing the whole spectrum of life sciences; 2) foster discussion, exchange of ideas, and promote collaborations and 3) enhance the training and development of young scientists and promote diversity. A high priority of the CN-GRC and CN- GRS is to increase the diversity of participants. Towards this goal, funds are requested for travel and registration support of female and under-represented speaker
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
"Extended dosing" immunization to enhance humoral immunity to next-generation vaccines
Localized immunotherapy using alum-binding therapeutics
Localized immunotherapy using alum-binding therapeutics
Localized immunotherapy using alum-binding therapeutics
海外基金